Search results
FDA Approves Gilead's Remdesivir For COVID-19 Treatment Patients With Severe Renal Impairment
Benzinga via Yahoo Finance· 11 months agoThe FDA approved Gilead Sciences Inc's (NASDAQ: GILD) supplemental new drug application for using...
New Oral COVID-19 Antiviral Might Be Better Than Pfizer's Paxlovid With Faster Recovery, Fewer Side...
Benzinga via Yahoo Finance· 1 year agoA study in China shows that a remdesivir analog, dubbed VV116, is as effective as Pfizer Inc's...
Humanigen (HGEN) Plunges as COVID Study Fails to Meet Goal
Zacks via Yahoo Finance· 2 years agoThe NIAID's ACTIV-5/BET-B study evaluating Humanigen's (HGEN) lenzilumab plus remdesivir in...
A One-Shot COVID-19 Treatment Shows Promise
Time via Yahoo News· 1 year agoCredit - Yiu Yu Hoi—Getty Images The current medicine chest for treating COVID-19 is fairly sparse. Only one drug—remdesivir—is approved by the U.S. Food...
WHO Recommends Gilead's COVID-19 Therapy For Severe Disease
Benzinga via Yahoo Finance· 2 years agoGilead Sciences Inc (NASDAQ: GILD) announced updates to the World Health Organization's (WHO)...
European Commission Signs COVID-19 Drug Procurement Deal With Gilead
Benzinga via Yahoo Finance· 2 years agoGilead Sciences Inc (NASDAQ: GILD) and the European Commission signed a joint procurement agreement...
Buy this Medical Sector Pioneer Stock
Zacks via Yahoo Finance· 2 years agoGilead Sciences GILD shares have continued to rise after beating on both its top and bottom lines in October. GILD stock is up roughly 20% since its Q3...
Gilead (GILD) Drugs Get Positive CHMP Opinion for Label Expansion
Zacks via Yahoo Finance· 2 years agoGilead Sciences, Inc. GILD recently announced that the Committee for Medicinal Products for Human...
Gilead (GILD) Q2 Earnings & Sales Top, Revenue Outlook Upped
Zacks via Yahoo Finance· 2 years agoGilead Sciences, Inc. GILD reported strong second-quarter results driven by continued solid demand...
Gilead Sciences Touts Encouraging Data From Real World Studies Of Its Flagship COVID-19 Treatment
Benzinga via Yahoo Finance· 1 year agoGilead Sciences Inc (NASDAQ: GILD) announced data from three retrospective real-world Veklury...